2025 |
Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study / A. Medvedeva, V. Chernov, M. Larkina [et al.] // ACS Pharmacology and Translational Science. – 2025. – Vol. 8, No 3. – P. 736–747, |
2025 |
Choice of an Optimal Modular Strategy for the Synthesis of DOTA-Containing Heterobivalent Agents Targeting PSMA and GRPr / S. A. Petrov, G. P. Grigoriev, G. A. Orlov [et al.] // Bioconjugate Chemistry. – 2024. – Vol. 36, No 4. – Р. 748–761. |
2024 |
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors / M. S. Larkina., R. N. Varvashenya, Y. Yuldasheva [et al.]. – DOI 10.1021/acs.molpharmaceut.3c01173 // Molecular Pharmaceutics. – 2024. – Vol. 21, No 4. – P. 1919-1932. |
2024 |
Новые способы синтеза двух простетических групп ([123I]SIB и [123I]IHPEM) для радиоиодирования каркасных белков / Л. А. Хасново, М. С. Ларькина, Г. Е. Янович [и др.] // Бутлеровские сообщения. – 2024. – Т. 79, № 7. – С. 67-80. – DOI 10.37952/ROI-jbc-01/24-79-7-67. |
2024 |
Оценка функциональной пригодности лиофилизата таргетных каркасных белков с анкириновыми повторами для радионуклидной визуализации гиперэкспрессии HER2/neu в злокачественных опухолях / Р. Н. Варвашеня, А. А. Прач, Е. B. Плотников [и др.] // Бюллетень сибирской медицины. – 2024. – Т. 23, № 3. – С. 16-24. |
2024 |
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer / R. Zelchan, V. Chernov, A. Medvedeva [et al.] // Cancers. – 2024. – Vol. 16, No. 16. – URL: https://www.cambridge.org/core/journals/european-psychiatry/article/protective-effect-of-lithium-pyruvate-against-oxidative-damage-to-peripheral-blood-mononuclear-cells/07740058B78F99FF96A31DC3AE13EB73# – Published: 10 August 2024. |
2024 |
Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation / A. Popov, N. Suvorov, M. Larkina [et al.]. – DOI 10.3390/molecules30010117 // Molecules. – 2025. – Vol. 30, No. 1. – URL: https://www.mdpi.com/1420-3049/30/1/117. – Published: 31 December 2024. |
2024 |
A new SPECT agent for PSMA visualization, [99mTc]Tc-BQ0413: preclinical evaluation and preliminary results of Phase I clinical study : [abstracts from Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 19-23 October 2024] / A. Orlova, E. Bezverkhniaia, P. Kanellopoulos [et al.] // European Journal of Nuclear Medicine And Molecular Imaging. – 2024. – Vol. 51, Suppl. 1. – URL: https://link.springer.com/article/10.1007/s00259-024-06838-z. – Published: 27 September 2024. |